How many insider declarations has Press Joseph filed?

Press Joseph has filed 1 public insider declaration with SEC (Form 4).

What is Press Joseph's role?

Press Joseph's reported role is not specified by the regulator across the filings.

Which companies does Press Joseph report trades for?

Press Joseph reports trades for Raphael Pharmaceutical Inc..

← Executives ★ Sign in to follow

PJ

Press Joseph

·SEC (Form 4)

Raphael Pharmaceutical Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by Press Joseph. Officer active across 1 company, notably Raphael Pharmaceutical Inc.. In total, 1 disclosures have been published. Activity tracked since 26 July 2022. The latest transaction was filed on 26 July 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Press Joseph

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Raphael Pharmaceutical Inc. (US)

申报1 总计

◆

Press Joseph

Director高管2022年7月26日Raphael Pharmaceutical Inc.

0SEC ↗

280,000 股0Common StockSEC:0001213900-23-019556:0

1 条申报中的 1 条

InsidersTradesSigma

← Executives ★ Sign in to follow

PJ

Press Joseph

·SEC (Form 4)

Raphael Pharmaceutical Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by Press Joseph. Officer active across 1 company, notably Raphael Pharmaceutical Inc.. In total, 1 disclosures have been published. Activity tracked since 26 July 2022. The latest transaction was filed on 26 July 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.